Pelles Sharon
- 23年の経験
- 所在地: イスラエル, テルアビブ
ペレス・シャロン医師は、ソウラスキー医療センターにて、SIRTおよびHIPECなどの革新的治療法を含む高度な肝癌治療を専門としています。
- 化学療法および免疫療法を含む包括的な肝癌治療を提供
- 肝切除術および高周波焼灼術を実施
- 癌治療に関する臨床研究に参加
- 肝癌に対する分子標的療法および化学塞栓療法を提供
- 続きを読む
イスラエルのトップ肝癌ステージ4医師と価格を比較。こちらで最適なマッチングを見つけてください
ご要望と予算に基づいて最適な医師を厳選いたします
医学的監修者 Fahad Mawlood
医学編集者・データサイエンティストトップ医師
12
イスラエル
レビュー
14000+
実際の患者より
個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし
最初に表示:
ペレス・シャロン医師は、ソウラスキー医療センターにて、SIRTおよびHIPECなどの革新的治療法を含む高度な肝癌治療を専門としています。
オフェル・メリムスキー教授はテルアビブ医療センターの腫瘍科を率い、進行がんの治療において41年の経験以上の経験を持ちます。
この医師は、消化管腫瘍の治療において30年以上の経験を持つ、著名な消化器専門医です。GIがんの予防、早期診断、および治療を専門としており、Sourasky Medical CenterのCancer Prevention Centerを率いています。
ヘブライ大学で一般医学の学位を取得し、テルアビブ大学で消化器学の専門を修了したこの医師は、NewYork-Presbyterian Centerで研究を行いました。この医師は300以上の論文を発表しており、American Association for Cancer ResearchやEuropean Society of Digestive Oncologyを含む、いくつかの著名な組織のメンバーです。
Dr. Einat Shacham Shmueli is a senior medical oncologist at Sheba Medical Center. She specializes in gastrointestinal cancers, treating the colon, stomach, and pancreas. Dr. Shacham Shmueli holds dual board certifications in oncology and gastroenterology. She trained at UCSF in the United States. Her clinic at Sheba Medical Center is ranked among the top 10 hospitals worldwide.
Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.
ソウラスキー医療センターの腫瘍内科部門を統括する、複雑な疾患に対応する中心的なリーダーです。
Dr. Ron Greenberg is an abdominal surgeon; a top specialist in open and minimally invasive and Whipple surgery as well. Has over 20 years of experience. Heads the Colorectal Surgery Department at Sourasky Medical Center.
Dr. Menahem Ben-haim is one of the top surgeons with overall experience for more than 28 years. He is among the best specialists to treat liver, pancreatic and other gastrointestinal cancers. The doctor manages Whipple surgery and other interventions to manage oncological conditions.
オーラ・ヒューバート博士はハダサ医療センターの医療腫瘍学者および放射線療法士で、英語とヘブライ語を話し、腫瘍学と放射線療法において33年の経験と資格を持っています。
Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.
アレクサンダー・ベニー博士は、ランバム医療センターの腫瘍学者であり、英語とヘブライ語を話し、この分野で豊富な経験と教育を受けています。
海外のクリニックを選ぶことはストレスフルです。800,000名以上の患者をサポートしたBookimedは、お客様の懸念を理解しています。信頼できる医師、最高の価格品質オプション、複雑なケースの解決策を見つける方法を知っています。すべての段階でお客様をご案内いたします。
ヤン・マツィイフスキー
医療コーディネーターチーム責任者
4300+件以上の患者の旅をガイド
Bookimedで3年
Israelの142名の患者が今月当社を通じて医師を見つけました
2分のクイズ
目標、予算、スケジュールをお聞かせください
人間のマッチング + AI
アルゴリズムがマッチングを見つけ、コーディネーターが適合性を確認します
オプション準備完了
価格、パッケージ、日程を比較。コーディネーターとチャット
選択肢に迷っていますか?
治療をガイド
医療訓練を受けた専属コーディネーター






| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 23年の経験 | 進行肝癌の治療法 | 肝臓がんに対するSIRTおよびHIPECなどの革新的治療を専門とする。患者の治療成績向上を目指した臨床研究にも積極的に取り組んでいる。 | イスラエル | から $825 | |
| #2 | 41年の経験 | 転移性肝癌 | テルアビブ医療センター腫瘍科長。パリにて専門研修を修了。転移症例を専門とするESMO肉腫グループのファカルティメンバー。 | イスラエル | から $950 | |
| #3 | 34年の経験 | 複合型肝癌第4期症例 | 主要な医療センターの部門長として、包括的な治療計画のためのチームを率いている。腫瘍内科の専門家。 | イスラエル | お問い合わせください |
Top specialists for stage 4 liver cancer in Israel include Dr. Ofer Merimsky at Sourasky Medical Center and Dr. Auala Hubert at Hadassah Medical Center. These board-certified experts specialize in managing metastatic disease through integrated chemotherapy, advanced radiotherapy, and SIRT therapy, which delivers radiation directly to liver tumors.
Bookimed Expert Insight: Patients with stage 4 liver cancer in Israel benefit from doctors who hold dual certifications. For example, Dr. Auala Hubert is board-certified in both medical oncology and radiotherapy. This allows one specialist to oversee both systemic drug treatments and targeted radiation, ensuring a faster, more cohesive plan for complex cases.
Patient Consensus: Patients emphasize moving quickly to progressive hospitals in Tel Aviv or Jerusalem to avoid treatment delays. They often feel more confident when cases are reviewed in multidisciplinary tumor boards instead of by one physician.
Israeli oncology specialists like Dr. Ofer Merimsky and Dr. Pelles Sharon use advanced techniques including Selective Internal Radiation Therapy (SIRT) and immunotherapy. These JCI-accredited centers focus on targeted radiation and molecular therapies to manage stage 4 liver cancer and extend patient survival.
Bookimed Expert Insight: Israeli specialists like Dr. Auala Hubert often hold dual qualifications in medical oncology and radiotherapy. This allows them to integrate systemic drug treatments with precise radiation like CyberKnife without coordinating between separate departments. This unified approach is especially effective for managing complex stage 4 cases in Jerusalem and Tel Aviv clinics.
Patient Consensus: Patients mention that intensive treatments like TIL therapy are physically exhausting and require good health. Many find that tumor mutation testing is a vital step to match them with clinical trials. They see IV chemotherapy as a fallback when targeted options are not suitable for their condition.
Israeli doctors are highly experienced in non-surgical liver cancer treatment, using advanced therapies like SIRT and radiofrequency ablation. Specialists at JCI-accredited centers like Sourasky and Sheba manage stage 4 cases when surgery is not possible. Many have 25+ years of experience and hold US or European board certifications.
Bookimed Expert Insight: Israeli specialists often combine therapies like SIRT with immunotherapy to treat metastatic liver cancer. Data shows that leaders like Prof. Ofer Merimsky frequently manage complex cases by integrating targeted drugs. This multi-layered approach helps control tumor growth when standard surgical options are ruled out.
Patient Consensus: Patients mention that Israeli centers offer advanced options like Oncosil and DaRT for non-resectable tumors. People say they felt relieved after finding doctors who use focused radiation and novel clinical trials. They noticed that specialists prioritize preserving liver function while aggressively treating the cancer cells.
Oncologists at top Israeli centers hold board certifications in oncology and radiotherapy. Many specialists, such as Dr. Alexander Beny at Rambam, maintain dual certifications in Israel and Europe. These doctors often complete fellowships at prestigious US institutions like Harvard or New York Medical College to master advanced liver cancer treatments.
Bookimed Expert Insight: Israeli specialists often hold dual board certifications in both medical oncology and radiotherapy. For example, Prof. Auala Hubert at Hadassah is certified in both fields. This allows one doctor to manage systemic chemotherapy and precise radiation like CyberKnife, which is helpful for complex liver cases.
Patient Consensus: Patients emphasize choosing doctors with specific fellowship training in liver cancer rather than just relying on a clinic's reputation. They feel more secure knowing these specialists are government-regulated employees at well-established public hospitals.
Israeli nuclear medicine experts use metabolic imaging to identify liver tumors and confirm cancer spread with high precision. These specialists perform PET/CT scans to differentiate between benign and malignant tissue. This ensures accurate staging, which is vital for patients with stage 4 illness to receive appropriate systemic therapies.
Bookimed Expert Insight: Israeli specialists often combine nuclear medicine expertise with interventional oncology for complex cases. For instance, Dr. Pelles Sharon at Sourasky Medical Center integrates SIRT therapy directly into advanced treatment protocols. This dual focus allows for real-time adjustments to therapy based on how the liver tumor metabolizes radioactive tracers.
Patient Consensus: Patients value nuclear medicine as a high-end service for resolving diagnostic uncertainty. They often seek these specialized scans for a thorough second opinion when original staging feels incomplete. Many feel more confident when teams explain exactly how imaging results will change their treatment plan.